Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

TGF-beta2 specific phosphorothioate antisense oligodeoxynucleotide

EU orphan designation number: EU/3/02/091   
Active ingredient: TGF-beta2 specific phosphorothioate antisense oligodeoxynucleotide
Indication: Treatment of high-grade glioma
Sponsor: Isarna Therapeutics GmbH
Leopoldstr. 254-256, 80807 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
27/03/2002 Orphan Designation EMEA/OD/073/01 (2002)1293 of 22/03/2002
04/02/2014 Change name of sponsor